ivabradine has been researched along with Arrhythmia in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (19.15) | 29.6817 |
| 2010's | 27 (57.45) | 24.3611 |
| 2020's | 11 (23.40) | 2.80 |
| Authors | Studies |
|---|---|
| Hofmann, F; Ludwig, A; Stieber, J; Stöckl, G; Wieland, K | 1 |
| Bertero, A; Cain, K; Dupras, S; El-Nachef, D; Futakuchi-Tsuchida, A; Jayabalu, A; Kalucki, FA; Kattman, S; Knollmann, BC; MacLellan, WR; Marchianò, S; Murry, CE; Nakamura, DS; Nakamura, K; Neidig, LE; Pabon, L; Reinecke, H; Robinson, MR; Thies, RS; Tian, R; Tsuchida, H; Weber, GJ; Whittington, D; Yang, X | 1 |
| Depuydt, AS; Peigneur, S; Tytgat, J | 1 |
| Almorad, A; Bala, G; Beaver, TM; Brodt, CR; Brugada, P; Chierchia, GB; de Asmundis, C; Gauthey, A; La Meir, M; Lakkireddy, D; Lee, RJ; Monaco, C; Olshansky, B; Overeinder, I; Pannone, L; Sieira, J; Sorgente, A; Ströker, E | 1 |
| Penslar, J; Udupa, S | 1 |
| Gao, W; Guo, Y; Huang, M; Li, F; Liu, T; Xu, X | 1 |
| Ergul, Y; Gul, O; Kafali, HC | 1 |
| Çetin, T; Çınar, T; Çinier, G; Eren, S; Hayıroğlu, Mİ; Keskin, K; Pay, L; Tekkeşin, Aİ; Tezen, O; Yumurtaş, AÇ | 1 |
| Amstetter, D; Badt, F; Bittner, RE; Ebner, J; Hilber, K; Koenig, X; Rubi, L; Todt, H; Uhrin, P | 1 |
| Kruszewski, M; Leszek, P; Mackiewicz, U; Mączewski, M; Oknińska, M; Paterek, A; Śmigielski, W; Sochanowicz, B | 1 |
| Jæger, KH; Tveito, A; Wall, S | 1 |
| Mackiewicz, U; Mączewski, M; Marciszek, M; Oknińska, M; Paterek, A; Zambrowska, Z | 1 |
| Bisht, DS; Gokhroo, RK; Gupta, S; Kishore, K; Priti, K; Ranwa, BL | 1 |
| Çavuşoglu, Y; Mert, GÖ; Mert, KU; Morrad, B; Mutlu, F; Tahmazov, S | 1 |
| Dechering, DG; Eckardt, L; Ellermann, C; Frommeyer, G; Kaese, S; Kochhäuser, S; Lange, PS; Weller, J | 1 |
| Hancox, JC | 1 |
| Chobanyan-Jürgens, K; Duncker, D; Heusser, K; Jordan, J; Luft, FC; May, M; Mehling, H; Schröder, C; Tank, J; Veltmann, C | 1 |
| Mert, GÖ; Mert, KU; Şener, E | 1 |
| Ghadimi, N; Hosseinifard, H; Kaveh, S; Lijassi, A; Mehr, AZ; Shabaninejad, H | 1 |
| Lyon, AR; Ng, FS; Peters, NS; Shadi, IT | 1 |
| Arai, Y; Igata, S; Kinoshita, H; Kuwabara, Y; Kuwahara, K; Minami, T; Nakagawa, Y; Nakao, K; Nishikimi, T; Shibata, J; Takano, M; Ueshima, K; Usami, S; Yamada, C; Yamada, Y; Yasuno, S | 1 |
| Chu, S; Dobrzynski, H; Duda, M; Gerges, JY; Lewartowski, B; Mackiewicz, U; Mączewski, M | 1 |
| De Santis, V; Frati, G; Greco, E; Tritapepe, L | 1 |
| Alig, J; Bidaud, I; Dubel, S; Ehmke, H; Engeland, B; Eschenhagen, T; Fernandez, A; Isbrandt, D; Mangoni, ME; Marger, L; Marquilly, C; Mesirca, P; Miquerol, L; Müller, JC; Nargeot, J; Rollin, A; Seniuk, A; Singh, J; Torrente, AG; Vincent, A; Wickman, K | 1 |
| Caetano, J; Delgado Alves, J | 1 |
| Al-Kindi, SG; Oliveira, GH; Orasanu, G | 1 |
| Bellin, M; Chen, Z; Dorn, T; Dreizehnter, L; Goedel, A; Hinkel, R; Laugwitz, KL; Lipp, P; Moretti, A; Mummery, CL; Ng, JK; Pane, LS; Schneider, CM; Sinnecker, D; Tian, Q; Ward-van Oostwaard, D; Xian, W | 1 |
| Lancellotti, P | 1 |
| Ferrari, R; Ford, I; Fox, K; Robertson, M; Steg, PG; Tendera, M | 1 |
| Heusch, G | 1 |
| Akdemir, R; Balci, M; Dogan, M; Kara, E; Murat, SN; Orcan, S | 1 |
| Gardier, S; Pedretti, S; Raddatz, E; Sarre, A | 1 |
| DiMarco, JP; Mason, PK | 1 |
| DiFrancesco, D | 1 |
| D'Angelo, L; Fazio, G; Licata, P; Novo, G; Novo, S; Passantino, S; Sarulo, F; Spanò, C; Visconti, C; Zarcone, P | 1 |
| Bhargava, B; Parakh, N | 1 |
| Ferrari, R; Fox, KM | 1 |
| Baczkó, I; Bitay, M; Cerbai, E; Fülöp, F; Jaeger, K; Jost, N; Koncz, I; Kristóf, A; Orvos, P; Papp, JG; Szél, T; Tálosi, L; Varró, A; Virág, L | 1 |
| Fruhwald, F; Pieske, B | 1 |
| Böhm, M; Borer, JS; Ford, I; Komajda, M; O'Meara, E; Swedberg, K; Tardif, JC; Tavazzi, L | 1 |
| Böhm, M; Borer, JS; Chassany, O; Ekman, I; Ford, I; Komajda, M; Swedberg, K; Tavazzi, L | 1 |
| Clark, AL; Cleland, JG; Cullington, D; Goode, KM | 1 |
| Castagno, D; Claggett, B; McMurray, J; Petrie, MC | 1 |
| Drożdż, J; Filipiak, KJ; Grajek, S; Kasprzak, JD; Opolski, G; Rynkiewicz, A; Stępińska, J; Tykarski, A; Wożakowska Kapłon, B | 1 |
| Büter, I; Gams, E; Hohlfeld, T; Schipke, JD; Schmitz-Spanke, S | 1 |
| Menown, IB | 1 |
| Izzat, LM | 1 |
11 review(s) available for ivabradine and Arrhythmia
| Article | Year |
|---|---|
Review: HCN Channels in the Heart.
Topics: Arrhythmias, Cardiac; Cyclic Nucleotide-Gated Cation Channels; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Myocytes, Cardiac | 2022 |
Targeted Treatment of Inappropriate Sinoatrial Node Tachycardia Based on Electrophysiological and Structural Mechanisms.
Topics: Animals; Arrhythmias, Cardiac; Heart Rate; Humans; Ivabradine; Sinoatrial Node; Tachycardia; Tachycardia, Sinus | 2022 |
Effect of ivabradine on cardiac arrhythmias: Antiarrhythmic or proarrhythmic?
Topics: Arrhythmias, Cardiac; Cardiovascular Agents; Heart Rate; Humans; Ivabradine | 2021 |
Comparative efficacy of ivabradine versus beta-blockers in patients with mitral stenosis in sinus rhythm: systematic review and meta-analysis.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Cardiovascular Agents; Heart Rate; Humans; Ivabradine; Mitral Valve Stenosis; Randomized Controlled Trials as Topic; Treatment Outcome | 2019 |
Heart rate and cardiovascular protection.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Atherosclerosis; Benzazepines; Cardiovascular Agents; Clinical Trials as Topic; Heart Failure; Heart Rate; Humans; Hypertension; Ivabradine; Myocardial Ischemia; Risk Factors | 2015 |
New pharmacological agents for arrhythmias.
Topics: Acetanilides; Adenosine A1 Receptor Agonists; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Benzofurans; Clinical Trials as Topic; Dronedarone; Humans; Ivabradine; Piperazines; Pyrrolidines; Ranolazine | 2009 |
Funny channel-based pacemaking.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Heart Conduction System; Heart Rate; Humans; Ion Channels; Ivabradine; Mutation | 2010 |
Rate control with ivabradine: angina pectoris and beyond.
Topics: Acute Coronary Syndrome; Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Heart Failure; Heart Rate; Humans; Ivabradine | 2011 |
Heart rate: a forgotten link in coronary artery disease?
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Arteriosclerosis; Benzazepines; Coronary Artery Disease; Coronary Vessels; Disease Progression; Elasticity; Endothelium, Vascular; Heart Rate; Hemodynamics; Humans; Ivabradine; Myocardial Ischemia; Myocardium; Oxygen Consumption | 2011 |
[Selective I(f) channel inhibition: an alternative for treating coronary artery disease?].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Clonidine; Coronary Artery Disease; Humans; Isoindoles; Ivabradine; Phthalimides; Practice Guidelines as Topic; Practice Patterns, Physicians' | 2006 |
Ivabradine: a new strategy for management of stable angina.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Calcium Channel Blockers; Clinical Trials as Topic; Exercise Tolerance; Humans; Ivabradine; Treatment Outcome | 2007 |
6 trial(s) available for ivabradine and Arrhythmia
| Article | Year |
|---|---|
Ivabradine vs metoprolol in patients with acute inferior wall myocardial infarction-"Expanding arena for ivabradine".
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Atrioventricular Block; Benzazepines; Cardiotonic Agents; Double-Blind Method; Electrocardiography; Endpoint Determination; Female; Heart Block; Heart Failure; Humans; Inferior Wall Myocardial Infarction; Ivabradine; Male; Metoprolol; Middle Aged; Prospective Studies; Recurrence; Survival Analysis | 2017 |
Cardiac pacemaker channel (HCN4) inhibition and atrial arrhythmogenesis after releasing cardiac sympathetic activation.
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Autonomic Nervous System; Blood Pressure; Cardiovascular Agents; Cross-Over Studies; Double-Blind Method; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Muscle Proteins; Pacemaker, Artificial; Potassium Channels; Prospective Studies; Young Adult | 2018 |
Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.
Topics: Adult; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Coronary Artery Disease; Death, Sudden, Cardiac; Double-Blind Method; Female; Hospitalization; Humans; Ivabradine; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Ventricular Dysfunction, Left; Young Adult | 2009 |
Arrhythmic effects of ivabradine in patients with coronary artery disease.
Topics: Adult; Aged; Arrhythmias, Cardiac; Benzazepines; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged | 2009 |
Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Double-Blind Method; Echocardiography; Female; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Remodeling | 2011 |
Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Cause of Death; Chronic Disease; Double-Blind Method; Female; Heart Failure, Systolic; Humans; Ivabradine; Male; Middle Aged; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2011 |
30 other study(ies) available for ivabradine and Arrhythmia
| Article | Year |
|---|---|
Bradycardic and proarrhythmic properties of sinus node inhibitors.
Topics: Animals; Arrhythmias, Cardiac; Benzazepines; Bradycardia; Cardiotonic Agents; Cloning, Molecular; Electrocardiography; Humans; Ivabradine; Mice; Mice, Inbred C57BL; Piperidines; Sinoatrial Node; Up-Regulation | 2006 |
Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cell Line; Cell- and Tissue-Based Therapy; Disease Models, Animal; Drug Combinations; Humans; Ivabradine; Male; Myocardial Infarction; Myocytes, Cardiac; Pluripotent Stem Cells; Stem Cell Transplantation; Swine; Tachycardia | 2021 |
Ivabradine in the Management of Pediatric Arrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiovascular Agents; Child; Heart Rate; Humans; Ivabradine | 2023 |
Ivabradine monotherapy in pediatric patients with focal atrial tachycardia: a single-center study.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Child; Female; Humans; Ivabradine; Stroke Volume; Tachycardia; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2023 |
Successful treatment of the focal ectopic atrial tachycardia in an infant with a single dose of ivabradin.
Topics: Arrhythmias, Cardiac; Catheter Ablation; Electrocardiography; Humans; Infant; Ivabradine; Male; Tachycardia, Ectopic Atrial; Tachycardia, Supraventricular | 2023 |
Effect of ivabradine on ventricular arrhythmias in heart failure patients with reduced ejection fraction.
Topics: Arrhythmias, Cardiac; Heart Failure; Humans; Ivabradine; Retrospective Studies; Stroke Volume; Tachycardia, Ventricular; Ventricular Dysfunction, Left | 2023 |
The bradycardic agent ivabradine decreases conduction velocity in the AV node and in the ventricles in-vivo.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrioventricular Node; Cardiac Pacing, Artificial; Disease Models, Animal; Electrocardiography; Female; Heart Rate; Ivabradine; Mice, Inbred C57BL; Time Factors | 2021 |
Ivabradine prevents deleterious effects of dopamine therapy in heart failure: No role for HCN4 overexpression.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dopamine; Female; Heart Failure; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Muscle Proteins; Myocardium; Potassium Channels; Rats, Wistar; Ventricular Function, Left; Ventricular Remodeling | 2021 |
Computational prediction of drug response in short QT syndrome type 1 based on measurements of compound effect in stem cell-derived cardiomyocytes.
Topics: Action Potentials; Adult; Ajmaline; Algorithms; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cell Line; Computational Biology; Drug Evaluation, Preclinical; Electrocardiography; ERG1 Potassium Channel; Heart Conduction System; Heart Defects, Congenital; Humans; In Vitro Techniques; Induced Pluripotent Stem Cells; Ivabradine; Mexiletine; Models, Cardiovascular; Mutation; Myocytes, Cardiac; Quinidine; Translational Research, Biomedical | 2021 |
Effects of ivabradine and beta-blocker therapy on dobutamine-induced ventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Dobutamine; Electrocardiography, Ambulatory; Female; Humans; Ivabradine; Male; Middle Aged | 2017 |
Antiarrhythmic properties of ivabradine in an experimental model of Short-QT- Syndrome.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Ivabradine; Refractory Period, Electrophysiological; Ventricular Dysfunction | 2017 |
Could ivabradine be a new treatment for the short QT syndrome?
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Ivabradine; Models, Theoretical | 2017 |
Beneficial effects of ivabradine in atrial or ventricular arrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Humans; Ivabradine; Tachycardia, Ectopic Junctional | 2018 |
Selective heart rate reduction with ivabradine slows ischaemia-induced electrophysiological changes and reduces ischaemia-reperfusion-induced ventricular arrhythmias.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Heart Rate; Ivabradine; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Ventricular Fibrillation | 2013 |
Increased expression of HCN channels in the ventricular myocardium contributes to enhanced arrhythmicity in mouse failing hearts.
Topics: Animals; Arrhythmias, Cardiac; Benzazepines; Cations; Heart Failure; Heart Ventricles; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Mice; Mice, Transgenic | 2013 |
Ivabradine protects against ventricular arrhythmias in acute myocardial infarction in the rat.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Calcium; Gene Expression Regulation; Ivabradine; Male; Myocardial Infarction; Potassium Channels; Rats; Rats, Inbred WKY | 2014 |
Ivabradine: a preliminary observation for a new terapeutic role in patients with multiple organ dysfunction syndrome.
Topics: Aged; Arrhythmias, Cardiac; Benzazepines; Cardiovascular Agents; Humans; Ivabradine; Male; Middle Aged; Multiple Organ Failure; Pilot Projects; Sepsis; Treatment Outcome | 2014 |
Cardiac arrhythmia induced by genetic silencing of 'funny' (f) channels is rescued by GIRK4 inactivation.
Topics: Animals; Arrhythmias, Cardiac; Benzazepines; Calcium Signaling; Disease Models, Animal; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle Proteins; Myocytes, Cardiac; Oocytes; Patch-Clamp Techniques; Potassium Channels; Pregnancy; Xenopus | 2014 |
Ivabradine in Management of Heart Failure: a Critical Appraisal.
Topics: Arrhythmias, Cardiac; Benzazepines; Cardiomyopathies; Cardiovascular Agents; Clinical Studies as Topic; Heart Failure; Heart Rate; Heart Transplantation; Humans; Ivabradine; Shock, Cardiogenic; Ultrasonography | 2016 |
Subtype-specific promoter-driven action potential imaging for precise disease modelling and drug testing in hiPSC-derived cardiomyocytes.
Topics: Action Potentials; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Case-Control Studies; Cisapride; Drug Evaluation; Humans; Induced Pluripotent Stem Cells; Ivabradine; Long QT Syndrome; Luminescent Proteins; Models, Cardiovascular; Myocytes, Cardiac; Potassium Channel Blockers; Voltage-Sensitive Dye Imaging | 2017 |
[Ivabradine (Procoralan)].
Topics: Arrhythmias, Cardiac; Benzazepines; Exercise; Heart Rate; Humans; Ischemia; Ivabradine | 2008 |
A BEAUTIFUL lesson--ivabradine protects from ischaemia, but not from heart failure: through heart rate reduction or more?
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Coronary Artery Disease; Heart Failure; Humans; Ivabradine; Myocardial Ischemia; Retrospective Studies; Ventricular Dysfunction, Left | 2009 |
Specific inhibition of HCN channels slows rhythm differently in atria, ventricle and outflow tract and stabilizes conduction in the anoxic-reoxygenated embryonic heart model.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Biological Clocks; Blotting, Western; Chick Embryo; Cyclic Nucleotide-Gated Cation Channels; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Excitation Contraction Coupling; Heart; Heart Atria; Heart Conduction System; Heart Rate; Heart Ventricles; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Hypoxia; Ivabradine; Myocardial Contraction; Oxygen; Potassium Channels; Time Factors; Tissue Culture Techniques | 2010 |
Ivabradine versus bisoprolol.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Bisoprolol; Heart Rate; Humans; Ivabradine; Male; Middle Aged | 2010 |
Electrophysiological effects of ivabradine in dog and human cardiac preparations: potential antiarrhythmic actions.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Dogs; Dose-Response Relationship, Drug; Electrophysiological Phenomena; Heart; Humans; Ivabradine; Kinetics; Potassium; Rabbits; Sodium Channel Blockers | 2011 |
Left ventricular remodelling in systolic heart failure using ivabradine. Slower is smaller is better?
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Female; Heart Failure; Humans; Ivabradine; Male; Ventricular Dysfunction, Left; Ventricular Remodeling | 2011 |
Limited role for ivabradine in the treatment of chronic heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Benzazepines; Cardiotonic Agents; Chronic Disease; Female; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Patient Selection; Stroke Volume; Ventricular Dysfunction, Left | 2011 |
Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Digoxin; Female; Heart Failure; Humans; Ivabradine; Kaplan-Meier Estimate; Male; Middle Aged; Randomized Controlled Trials as Topic; Retrospective Studies; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left | 2012 |
[Optimum heart rate - the current goal of cardiovascular therapy. Position statement of the Polish Cardiac Society Working Group on Cardiovascular Drug Therapy].
Topics: Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Digoxin; Diltiazem; Heart Diseases; Heart Rate; Humans; Hypertension; Ivabradine; Verapamil | 2012 |
The role of heart rate reduction in angina management and beyond.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Cardiotonic Agents; Heart Rate; Humans; Ivabradine; Risk Factors | 2008 |